Entering text into the input field will update the search result below

Alcobra to merge with Arcturus Therapeutics in all-stock deal; shares ahead 15% premarket

  • Thinly traded nano cap Alcobra (ADHD) is up 15% premarket on light volume on the news that it has agreed to merge with privately held Arcturus Therapeutics in an all-stock transaction. The combined company will focus on developing RNA medicines to treat infectious diseases, cystic fibrosis, NASH and rare liver diseases.
  • Under the terms of the merger agreement, Alcobra shareholders will own ~40% of the combined firm while Arcturus shareholders will own ~60%. The deal should close in Q4.
  • The companies will host a conference call this morning at 8:30 am ET to discuss the merger.

Recommended For You

About ARCT Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
ARCT--
Arcturus Therapeutics Holdings Inc.